Inventors:
YU LI - ANDOVER MA, US
DAVID LOMBARD - Ann Arbor MI, US
International Classification:
A61K 39/395, C07K 16/00, A61P 3/00, G01N 33/566
US Classification:
4241391, 5303879, 5303873, 5303917, 4241831, 436501
Abstract:
The invention discloses 1302 novel acetylation sites peptides (including AQUA peptides) comprising an acetylation site of the invention, antibodies specifically bind to a novel acetylation site of the invention, and diagnostic and therapeutic uses of the above. The acetylation sites identified provide important information regarding metabolism in energy signaling pathways.